ANEB Annual CFF
-$62.40 K
-$6.44 M-100.98%
30 June 2024
Summary:
As of January 23, 2025, ANEB annual cash flow from financing activities is -$62.40 thousand, with the most recent change of -$6.44 million (-100.98%) on June 30, 2024. During the last 3 years, it has fallen by -$21.89 million (-100.29%). ANEB annual CFF is now -100.29% below its all-time high of $21.83 million, reached on June 30, 2021.ANEB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANEB Quarterly CFF
N/A
30 September 2024
Summary:
ANEB quarterly cash flow from financing activities is not available.ANEB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANEB TTM CFF
N/A
30 September 2024
Summary:
ANEB TTM cash flow from financing activities is not available.ANEB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANEB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -101.0% | - | - |
| 3 y3 years | -100.3% | - | - |
| 5 y5 years | - | - | - |
ANEB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.3% | at low | ||||
| 5 y | 5-year | -100.3% | at low | ||||
| alltime | all time | -100.3% | at low |
Anebulo Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | -$62.40 K(-101.0%) | $0.00(0.0%) | -$62.40 K(-52.2%) |
| Mar 2024 | - | $0.00(-100.0%) | -$130.60 K(0.0%) |
| Dec 2023 | - | -$62.40 K(-8.5%) | -$130.60 K(-102.0%) |
| June 2023 | $6.38 M | -$68.20 K(<-9900.0%) | $6.38 M(-1.1%) |
| Mar 2023 | - | $0.00(-100.0%) | $6.45 M(0.0%) |
| Dec 2022 | - | -$248.90 K(-103.7%) | $6.45 M(-3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $6.70 M(>+9900.0%) | $6.70 M(>+9900.0%) |
| June 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2022 | - | $0.00(0.0%) | $20.18 M(-7.6%) |
| Dec 2021 | - | $0.00(0.0%) | $21.83 M(0.0%) |
| Sept 2021 | - | $0.00(-100.0%) | $21.83 M(0.0%) |
| June 2021 | $21.83 M | $20.18 M(+1118.4%) | $21.83 M(+1218.4%) |
| Mar 2021 | - | $1.66 M | $1.66 M |
FAQ
- What is Anebulo Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals annual CFF year-on-year change?
- What is the all time high quarterly CFF for Anebulo Pharmaceuticals?
- What is the all time high TTM CFF for Anebulo Pharmaceuticals?
What is Anebulo Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of ANEB is -$62.40 K
What is the all time high annual CFF for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high annual cash flow from financing activities is $21.83 M
What is Anebulo Pharmaceuticals annual CFF year-on-year change?
Over the past year, ANEB annual cash flow from financing activities has changed by -$6.44 M (-100.98%)
What is the all time high quarterly CFF for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high quarterly cash flow from financing activities is $20.18 M
What is the all time high TTM CFF for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high TTM cash flow from financing activities is $21.83 M